Tci Wealth Advisors, Inc. Alector, Inc. Transaction History

Tci Wealth Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$7.65 - $14.24 $803 - $1,495	105 Added 39.77%	369 $4,000
Q1 2022 Apr 29, 2022	BUY	$13.02 - $20.78 $976 - $1,558	75 Added 39.68%	264 $4,000
Q4 2021 Jan 24, 2022	BUY	$19.35 - $25.54 $909 - $1,200	47 Added 33.1%	189 $4,000
Q1 2021 Apr 29, 2021	BUY	$14.84 - $22.23 $2,107 - $3,156	142 New	142 $3,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.